Why Guardian Pharmacy Services, Inc.’s (GRDN) Stock Is Down 5.13%

By Cynthia McLaughlin
August 01, 2026
Featured Tickers:

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Guardian Pharmacy Services, Inc. before investing.

In this article, we go over a few key elements for understanding Guardian Pharmacy Services, Inc.’s stock price such as:

  • Guardian Pharmacy Services, Inc.’s current stock price and volume
  • Why Guardian Pharmacy Services, Inc.’s stock price changed recently
  • Upgrades and downgrades for GRDN from analysts
  • GRDN’s stock price momentum as measured by its relative strength

About Guardian Pharmacy Services, Inc. (GRDN)

Before we jump into Guardian Pharmacy Services, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company’s individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. Its Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine technology to examine prescriptions and detect omissions and/or errors before they become a customer service problem; and Medication Spend Analyzer to break down the monthly drug spending for each of the LTCFs. Guardian Pharmacy Services, Inc. was founded in 2003 and is headquartered in Atlanta, Georgia.

Want to learn more about Guardian Pharmacy Services, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Guardian Pharmacy Services, Inc..

Learn More About A+ Investor

Guardian Pharmacy Services, Inc.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, Guardian Pharmacy Services, Inc.’s stock price was $39.530.

Guardian Pharmacy Services, Inc. is down 4.05% from its previous closing price of $41.200.

During the last market session, Guardian Pharmacy Services, Inc.’s stock traded between $39.230 and $41.730. Currently, there are approximately 63.32 million shares outstanding for Guardian Pharmacy Services, Inc..

Guardian Pharmacy Services, Inc.’s price-earnings (P/E) ratio is currently at 47.3, which is high compared to the Health Care Providers & Services industry median of 26.7. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Guardian Pharmacy Services, Inc. Stock Price History

Guardian Pharmacy Services, Inc.’s (GRDN) price is currently down 5.59% so far this month.

During the month of July, Guardian Pharmacy Services, Inc.’s stock price has reached a high of $43.400 and a low of $37.030.

Over the last year, Guardian Pharmacy Services, Inc. has hit prices as high as $44.000 and as low as $19.295. Year to date, Guardian Pharmacy Services, Inc.’s stock is up 31.37%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Guardian Pharmacy Services, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there were 0 analysts who downgraded Guardian Pharmacy Services, Inc.’s stock and 2 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Guardian Pharmacy Services, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Guardian Pharmacy Services, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Guardian Pharmacy Services, Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Guardian Pharmacy Services, Inc. (GRDN) by visiting AAII Stock Evaluator.

Relative Price Strength of Guardian Pharmacy Services, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, Guardian Pharmacy Services, Inc. has a weighted four-quarter relative price strength of 10.72%, which translates to a Momentum Score of 84 and is considered to be Very Strong.

Want to learn more about how Guardian Pharmacy Services, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Guardian Pharmacy Services, Inc. Stock Price: Bottom Line

As of July 31, 2026, Guardian Pharmacy Services, Inc.’s stock price is $39.530, which is down 4.05% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Guardian Pharmacy Services, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Learn More About A+ Investor

Find New Stock Opportunities With Included With AAII Platinum
Est Rev: Up 5% Screen: 21.7% Compared to S&P 500
at only 6.9%

Since Inception. Data as of 12/31/2024.




Try AAII Platinum and get full access to
769.3% Stock Superstars Portfolio Total Return Since Inception
Compare to:
710.3% iShare DOW Jones
U.S. Index ETF (IYY)

SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.

Get your free copy of our special report analyzing the tech stocks most likely to outperform the market.

Download the FREE Report Here:

BECOME A MEMBER FOR ONLY $2

Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.